ArticleEvaluation of plasma fibrinogen and plasminogen activator inhibitor- 1 in type 2 diabetes mellitus patients with coronary artery disease
ArticleEvaluation of plasma fibrinogen and plasminogen activator inhibitor- 1 in type 2 diabetes mellitus patients with coronary artery disease
ArticleAssessment of the Natural Anticoagulants (Protein C, Protein S, and Antithrombin III) for COVID-19 Patients
ArticleAssessment of the Natural Anticoagulants (Protein C, Protein S, and Antithrombin III) for COVID-19 Patients
ArticleRelation between Hypercoagulability Effect of COVID-19 and the Occurrence of Acute Coronary Syndrome
ArticleRelation between Hypercoagulability Effect of COVID-19 and the Occurrence of Acute Coronary Syndrome